Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04255368 · ClinicalTrials.gov registry record · NA
Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response
A NA study, sponsored by Utah State University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT04255368: Completed NA study, sponsored by Utah State University.
NCT04255368 is a NA study that has completed, run by Utah State University. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04255368, a NA study, has completed, sponsored by Utah State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this research is to determine the production of trimethylamine-N-oxide (TMAO) from different forms of choline and whether this response is modified by the gut microbiota composition.
Primary Outcome
Plasma TMAO metabolite response
Interventions
- OTHER Water-soluble choline
- OTHER Fat-soluble choline
- OTHER No choline control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2017-11-09 |
| Est. Completion | 2020-07-25 |
| Phase | NA |
What the finished NCT04255368 record still lists
NCT04255368 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Water-soluble choline is the first listed.
NCT04255368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04255368 about?
NCT04255368 is a clinical study titled "Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response". The purpose of this research is to determine the production of trimethylamine-N-oxide (TMAO) from different forms of choline and whether this response is modified by the gut microbiota composition.
What is the current status of trial NCT04255368?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2017-11-09. Estimated completion is 2020-07-25.
What interventions are being tested in trial NCT04255368?
The interventions under investigation include: Water-soluble choline (OTHER), Fat-soluble choline (OTHER), No choline control (OTHER).
Who is sponsoring clinical trial NCT04255368?
This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04255368's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI